上客户端，和病友交流

点击下载

食道癌

Shirish Gadgeel M.D.

外科

Karmanos cancer center

擅长疾病

临床新药咨询

通过咨询找到适合自己的药物

去咨询

专家会诊咨询

专业、及时的一对一咨询

去咨询

如果您的问题未能解决，您还可以选择：

医学顾问

: 极速问诊

2万名名医
7*24小时为您匹配

1对1

: 找专家

肿瘤专科专家
对症找医专科专治

专家介绍

2015-06-19 14:362352

· Gender

· Male

· Multidisciplinary Team(s)

· Thoracic Oncology

· Department/Research Program(s)

· Clinical Arrangements

· Languages

· English
Hindi
Marathi

· Cancer Type(s)

· Lung Cancer (Small Cell & Non-Small Cell)
Mesothelioma
Esophageal Cancer

· Contact Info

· Email:
gadgeels@karmanos.org

· Education

· Fellowship
Hematology/oncology Fellowship: Wayne State University, Detroit, MI
Medical School
Grant Medical College, University of Bombay
Residency
Internal Medicine, Grant Medical College and J.J. Group of Hospitals, University of Bombay, Bombay, India
Residency
Internal Medicine Residency: Wayne State University, Detroit, MI
Graduate Training
Grant Medical College, University of Bombay

· Professional Memberships/Associations

· American Society of Clinical Oncology
International Association for the Study of Lung Cancer

· Board Certifications

· Medical Oncology
Hematology
American Board of Internal Medicine

· Clinical Interests

· Medical oncologist Multidisciplinary care of patients with lung cancer, mesothelioma and other chest cancers.

· Research Interests

· Clinical and Translational Research in Lung Cancer

· Profile

· Shirish M. Gadgeel, M.D., medical oncologist, leader of the Thoracic oncology Multidisciplinary Team at the Karmanos Cancer Center, President of the Medical Executive Committee of the Karmanos Cancer Center and associate professor of Hematology and oncology at Wayne State University School of Medicine, joined Karmanos in 2000. Dr. Gadgeel is also the medical director of the hematology/oncology inpatient unit. At Karmanos, Dr. Gadgeel is a member of various committees that review the scientific merit of proposed protocols to be conducted at Karmanos, and reviews and institutes various measures of quality of care for patients. He is also a member of the American Society of Clinical oncology and the Southwest oncology Group. His research focuses on conducting clinical and translational trials in the area of lung cancer and developmental therapeutics. Dr. Gadgeel's research interests have been funded by the National Cancer Institute, Southwest oncology Group, universities and pharmaceutical companies. He has won numerous awards including Wayne State University School of Medicine Teaching Award and the Merit Award from the American Society of Clinical Oncology. Dr. Gadgeel has authored more than 40 articles and seven book chapters, serves as reviewer for numerous journals, and sits on the editorial board of Clinical Lung Cancer. He received his M.D. in 1988 from Grant Medical College and J.J. Group of Hospitals at the University of Bombay in India. He completed a residency in internal medicine in India and an internship in internal medicine at LaGuardia Hospital in New York. Dr. Gadgeel completed a second residency in internal medicine and fellowship in hematology/oncology, both at Wayne State University School of Medicine. He also completed a fellowship in bone marrow transplantation at Wayne State University School of Medicine.

· Awards

· 1997 Merit Award, American Society of Clinical Oncology
1996 Outstanding Fellow, Division of Hematology & Oncology, Wayne State University, Detroit, MI
2012 National Cancer Institute Cancer Clinical Investigator Team Leadership Award
Voted one of Best Doctors Inc. 2011-2012 Best Doctors of the Year

· Publications

· Up-regulation of sonic hedgehog contributes to TGF-B1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One 2011 Jan;6 (1):e16068. PMID 21249152. Authors: Maitah MY, Ali S, Ahmad A, Gadgeel S, Sarkar FH.
Frequency and Type of Epidermal Growth Factor Receptor Mutations in African Americans with Non-small Cell Lung Cancer. J Thorac oncol 2011 March;6:627-30. PMID 21317742. Authors: Cote ML, Haddad R, Edwards DJ, Atikukke G, Gadgeel S, Soubani AO, Lonardo F, Bepler G, Schwartz AG, Ethier SP.
Soy Isoflavones Augment Radiation Effect by Inhibiting APE1/Ref-1 DNA Repair Activity in Non-small Cell Lung Cancer. J Thorac oncol 2011 April;6:688-98. PMID 21325978. Authors: Singh-Gupta V, Joiner MC, Runyan L, Yunker CK, Sarkar FH, Miller S, Gadgeel SM, Konski AA, Hillman GG.
Phase II study of pemetrexed and cisplatin with chest radiotherapy followed by docetaxel in patients with stage III Non Small Cell Lung Cancer. J Thorac oncol 2011 May;6:927-33. PMID 21415776. Authors: Gadgeel SM, Ruckdeschel JC, Patel BB, Wozniak A, Konski A, Valdivieso M, Hackstock D, Chen W, Belzer K, Burger AM, Marquette L, Turrisi A.
Hope and Realism: The Perfect Balance? J Clin oncol 2011;29:2291-2. PMID 21383299. Author: Gadgeel SM.

1. 添加医学顾问微信，扫描☟二维码

2. 备注【癌种】进病友群

扫描预约专家问诊

专家科普

【3月12日】肿瘤患者怎样避免人财两空？

493全球肿瘤医生网医学部
肿瘤临床试验患者真实采访（下）患者谈：临床试验是小白鼠吗？

600全球肿瘤医生网医学部
肿瘤临床试验患者真实采访（上）临床试验带来的希望

606全球肿瘤医生网医学部
胃癌IV期伴有肝脏及肝胃间隙淋巴结转移患者赴日就医

1343全球肿瘤医生网医学部
大肠癌伴肝转移患者赴日就医

998全球肿瘤医生网医学部
胶质母细胞瘤和髓母细胞瘤患者赴日就医

967全球肿瘤医生网医学部
肝癌患者日本国际就医案例

907全球肿瘤医生网医学部
癌症患者的新方案来了！数十位国际专家带先进技术助力国内癌症患者

1191全球肿瘤医生网医学部